Workflow
Revenue guidance narrowing
icon
Search documents
PTC Therapeutics narrows 2025 revenue guidance to $750M–$800M as Sephience launch accelerates (NASDAQ:PTCT)
Seeking Alpha· 2025-11-05 09:21
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...